SYNDOPA CR TAB10'S
Sun Pharmaceutical Industries Ltd
Product Information
Description
Syndopa CR Tablet (10s) is a combination medication containing Levodopa (200mg) and Carbidopa (50mg) used to manage symptoms of Parkinson's disease, such as tremors, stiffness, and slow movement. As a controlled-release (CR) formula, it increases dopamine levels in the brain to improve motor function and daily activity performance. It is typically taken with or after meals to minimize nausea.
Key Details for Syndopa CR Tablet (10s):Composition: Each controlled-release tablet usually contains 200 mg of Levodopa and 50 mg of Carbidopa.
Primary Use: Treatment of Parkinson's disease, including symptoms like muscle rigidity, tremor, and reduced movement control.
Mechanism: Levodopa converts into dopamine in the brain, while Carbidopa prevents its premature breakdown in the bloodstream.
Dosage: Swallow the tablet whole; do not chew or crush it.
Side Effects: Potential side effects include nausea, vomiting, dizziness, headache, dry mouth, and abnormal movements (dyskinesias).
Precautions: Avoid high-protein meals, which can interfere with absorption.